News & Updates
Filter by Specialty:
Antipsychotic resistance tied to poorer cognitive function in schizophrenia
Resistance to antipsychotic treatment may result in worse cognitive function among patients with schizophrenia, with disorganization, doses, and negative symptoms playing a major role in this association, according to a Singapore study.
Antipsychotic resistance tied to poorer cognitive function in schizophrenia
17 Oct 2024
Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
In the treatment of patients with rifampicin-resistant tuberculosis (TB), two bedaquiline-containing regimens, namely a 9-month all-oral regimen and a shorter 6-month regimen with 8 weeks of aminoglycoside, maintains superior efficacy to a 9-month injectable regimen through 132 weeks, according to long-term data from the STREAM 2 trial.
Bedaquiline-containing regimens show sustained benefit in rifampicin-resistant TB
16 Oct 2024
Phototherapy for psoriasis at home as good as in the office
Narrowband ultraviolet B (NB-UVB) phototherapy or light therapy performed at home is as good as one done in the doctor’s office in patients with plaque and guttate psoriasis, as shown in the randomized Light Treatment Effectiveness (LITE) trial presented at EADV 2024.
Phototherapy for psoriasis at home as good as in the office
15 Oct 2024
Psoriasis patients with overweight, obesity may need higher vunakizumab dosage
In the treatment of moderate-to-severe psoriasis, patients with overweight or obesity appear to have a diminished response to vunakizumab compared with those who have lower BMIs, according to a post hoc subgroup analysis of a phase III trial.